FindTrial
Sign In

Effectiveness of Prophylactic Intravenous Ondansetron to Reduce Pruritis after Intrathecal Fentanyl among Patients Undergoing Elective Cesarean Section in Worabe Comprehensive Specialized Hospital Southern Ethiopia, 2019.

Effectiveness of Prophylactic Intravenous Ondansetron to Reduce Pruritis after Intrathecal Fentanyl among Patients Undergoing Elective Cesarean Section in Worabe Comprehensive Specialized Hospital Southern Ethiopia, 2019.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR201911743087495
Enrollment
102
Registered
2019-11-11
Start date
2019-10-20
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Ondansetron
Normal saline placebo

Sponsors

worabe comprhensive specialized hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ASA I ASA II parturient aged>18 years old

Exclusion criteria

Exclusion criteria: Patients who refused to participate in the study History of a disorder associated with pruritus Patients having fentanyl allergy Patients with known allergy to ondansetron Patients who have existing itching with unknown cause Patients who took IV opioid and ondansetron preoperatively Patients having preexisting pregnancy induced pruritus Patients with complicated pregnancy

Design outcomes

Primary

MeasureTime frame
pruritus—

Secondary

MeasureTime frame
severity,onset and duration of pruritus—

Countries

Ethiopia

Contacts

Public ContactShukralla Shifa

MPH

shikshif1@gmail.com+25116362524

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026